Literature DB >> 28494848

Standards of Reporting Kampo Products (STORK) in research articles.

Yoshiharu Motoo1,2, Takashi Hakamatsuka1,3, Nobuo Kawahara1,4, Ichiro Arai1,5, Kiichiro Tsutani1,6.   

Abstract

There had been no standardized rules for citing ethical Kampo products used in clinical trials in journal articles. Although the name of a Kampo manufacturer was described in 77.9% of research articles, the name and ratios of crude drug components of Kampo formulas were not described in 77.5% of these papers. Considering the importance of proper characterization of interventions in the Consolidated Standards of Reporting Trials (CONSORT) checklist, we hereby propose the use of the Standards of Reporting Kampo Products (STORK) website, http://mpdb.nibiohn.go.jp/stork, as a reference for Kampo products. This will provide an official source on the internet for verified information on individual Kampo formulations for citation purposes in clinical research articles.

Mesh:

Substances:

Year:  2017        PMID: 28494848     DOI: 10.1016/S2095-4964(17)60347-9

Source DB:  PubMed          Journal:  J Integr Med


  3 in total

1.  Physician perspectives on traditional, complementary, and integrative medicine and the national evidence-based Japanese integrative medicine information website: A mixed-method study.

Authors:  Yoshiharu Motoo; Keiko Yukawa; Kazuho Hisamura; Ichiro Arai
Journal:  Integr Med Res       Date:  2020-06-20

2.  Use of Complementary and Alternative Medicine in Japan: A Cross-sectional Internet Survey Using the Japanese Version of the International Complementary and Alternative Medicine Questionnaire.

Authors:  Yoshiharu Motoo; Keiko Yukawa; Ichiro Arai; Kazuho Hisamura; Kiichiro Tsutani
Journal:  JMA J       Date:  2019-03-04

Review 3.  Kampo medicines for supportive care of patients with cancer: A brief review.

Authors:  Yoshiharu Motoo; Silke Cameron
Journal:  Integr Med Res       Date:  2022-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.